Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2014.032 | Online Modulation of Auditory Brainstem Responses to Speech | Prof. WONG Patrick Chun Man |
| 2013.663 | Microcephaly Genes, Language, and Auditory Processing | Prof. WONG Patrick Chun Man |
| 2017.102 | The Neurophysiological Basis of Early Speech Perception and Language Learning |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2014.412 | Neural responses to pitch in Cantonese-speaking children with autism spectrum disorders | Prof. WONG Patrick Chun Man |
| 2016.006 | Neurogenetics of English language learning in primary school children in Hong Kong |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2014.593 | Dopamine Genes and Language Learning in the Laboratory | Prof WONG Patrick Chun Man |
| 2015.410 | The Neural Basis of Language and Cognitive Development |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2021.523 | A Predict-to-Prescribe Approach to Social Communication Treatment in Chinese Preschool Children with Autism Spectrum Disorder |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2023.253 | Language and Brain Development in Urban and Rural Areas in China | Prof. WONG Patrick Chun Man |
| 2021.321 | Crosslinguistic influence in Ln (morpho-)syntactic acquisition |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2023.354 | Impact of Common Beliefs on Maternal and Child Health |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2022.515 | Hyperscanning to Explore the Human Mind in Ensembles |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2023.113 | Neural Encoding of Speech in Chinese-Learning Children | Prof. WONG Patrick Chun Man |
| 2021.155 | Creative Playgroup to Enhance Language Development in Infants and Toddlers: A Pilot Community Program |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2020.247 | Genetic Testing for Chinese Spoken and Written Language Disorders |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2019.077 | Using Neuroimaging to Predict Language Outcomes in Chinese-Learning Children with Cochlear Implants |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2020.328 | Family Risk of Autism in Chinese: Evidence at Behavioral, Neurological and Genetic Levels |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2020.144 | Using Advanced Neuroimaging to Predict Language and Cognitive Outcomes in Pre-Term Infants |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2019.680 | Neural-pragmatic relationships and cross linguistic differences in prosodic endophenotypes in autism |
Prof. WONG Patrick Chun Man 黃俊文 |
| 2011.134 | Evaluation of the environmental contamination levels & body contamination rate between two different removal methods in four types of protective clothing | Ms. WONG Peony Lai Ha |
| 2008.464 | A Descriptive Questionnaire Survey: The Factors Influence the Implementation of Auscultation by Nurses | Ms Wong Po Wa |
| 2021.273 | Optical Coherence Tomography and Optical Coherence Tomography Angiography features in Cytomegalovirus Retinitis | Dr. WONG Po Yin |
| 2020.081 | Characterising Right Ventricular Fibrosis and Abnormal Strain in Systemic Lupus Erythematosus with Pulmonary Hypertension – a Magnetic Resonance Imaging and Echocardiographic Correlation Study |
Dr. WONG Priscilla Ching Han 王靜嫻 |
| 2018.262 | Quantitative assessment of the spondyloarthritis severity by using Diffusion Weighted Imaging in 3T magnetic resonance imaging. |
Dr. WONG Priscilla Ching Han 王靜嫻 |
| 2005.198 | The Perception of Exercise from a Group of Older Adults with Knee Osteoarthritis in Hong Kong | WONG Pui Shan |
| 2025.895 | A comparison study of toe splint and toe spreader on foot pain and pressure reduction for patients with hallux valgus | Mr. WONG PUI YUI |
| 2024.006 | Infective endocarditis database | Prof. WONG Randolph Hung Leung |
| 2024.546 | Randomized control trial of Total Arch Replacement with Frozen Elephant Trunk versus Conventional Hemiarch Replacement in Patients with Acute Type A Aortic Dissection (TARFET-TAAD) | Prof. WONG Randolph Hung Leung |
| 2024.109 | Determinants of event-free survival and late reintervention after the Bentall procedure: A single-centre retrospective study |
Prof. WONG Randolph Hung Leung 黃鴻亮 |
| 2024.110 | Determinants of early and late survival after surgery for cardiac tumours |
Prof. WONG Randolph Hung Leung 黃鴻亮 |
| 2025.526 | A frailty-specific prehabilitation program for mild to moderately frail patients undergoing cardiac surgeries: A randomized sham-controlled trial | Prof. WONG Randolph Hung Leung |
| 2024.067 | AI-powered Multimodality approach to screen and diagnose Thoracic Aortic Aneurysm and Dissection (TAAD) |
Prof. WONG Randolph Hung Leung 黃鴻亮 |
| 2023.286 | Frailty trajectories and factors associated with frailty change among patients undergoing cardiac surgeries or transcatheter procedures: a mixed-methods prospective longitudinal study | Prof. WONG Randolph Hung Leung |
| 2023.075 | Randomized trial on Acutely Dissected Aorta Repair with Hemiarch replacement with or without stent implantation (RADAR trial) |
Prof. WONG Randolph Hung Leung 黃鴻亮 |
| 2022.083 | Radiogenomics approach to determine the prevalence of Genetically Triggered Thoracic Aortic Aneurysm and Dissection and guide genetic counselling in Hong Kong |
Dr. WONG Randolph Hung Leung 黃鴻亮 |
| 2021.236 | NEOS-APAC – Asian Pacific post-market clinical follow-up study in patients with acute or chronic aortic dissection or aortic aneurysm treated with E-vita OPEN NEO |
Dr. WONG Randolph Hung Leung 黃 鴻 亮 |
| 2015.669 | Pocket-size mobile echocardiographic device screening for thoracic aortic aneurysm in Chinese hypertensive patients |
Dr. WONG Randolph Hung Leung 黃鴻亮 |
| 2022.134 | Impact of cholesterol level on long-term angiographic outcome of CABG patients | Dr. WONG Randolph Hung Leung |
| 2024.394 | Mycophenolate mofetil in Chinese patients with immune thrombocytopenia | Dr. WONG Raymond |
| 2008.042 | A Phase 3 Randomized, Open-label Study of Bosutinib Versus Imatinib in Subjects With Newly Diagnosed Chronic Phase Phildadelphia Chromosome Positive Chronic Myelogenous Leukemia | Dr. WONG Raymond |
| 2026.135 | An Open-Label, Single-Arm, 3-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease | Dr. WONG Raymond Lai Man |
| 2026.269 | Exploratory Study of Ianalumab in Adults with Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) who Have Previously Benefited from Ianalumab (VAY RE-HIT) | Dr. Wong Raymond Siu Ming |
| 2024.694 | A Modular Phase II, Single-arm, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Surovatamig (AZD0486) in Participants with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (SOUNDTRACK-B) |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2025.284 | A Retrospective Analysis of Risk Factors, Treatments and Outcomes of Cancer-associated Venous Thromboembolism in Chinese Patients | Dr. WONG Raymond Siu Ming |
| 2024.596 | A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial of Quizartinib Administered in Combination with Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia (QuANTUM-Wild) | Dr. WONG Raymond Siu Ming |
| 2024.595 | A Phase III, Multicentre, Randomised, Open-label Study to Compare the Efficacy and Safety of AZD0486 plus Rituximab versus Chemotherapy plus Rituximab in Previously Untreated Participants with Follicular Lymphoma (SOUNDTRACK-F1) |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2024.660 | Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects with Severe or Moderately Severe Hemophilia B with Detectable Pretreatment AAV5 Neutralizing Antibodies | Dr. WONG Raymond Siu Ming |
| 2024.390 | The disease epidemiology and treatment of haemophilia A and B patients in Hong Kong |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2025.862 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination with Intensive Chemotherapy in Participants with Newly Diagnosed AML with an NPM1 mutation (REVEAL-ND NPM1) |
Dr. Wong Raymond Siu Ming 王紹明 |
| 2026.077 | EVALUATING EFFECTIVENESS AND SAFETY OF GLOFITAMAB BASED SECOND-LINE THERAPY IN CHINESE ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A PROSPECTIVE, OBSERVATIONAL, MULTICENTER, COHORT STUDY | Dr. Wong Raymond Siu Ming |
Page 255 of 288.